Combination therapy for early Alzheimer's disease: what are we waiting for?
Journal Article
The practical pharmacological approaches currently available to palliate the cognitive and functional losses in early Alzheimer's disease (AD) include cholinesterase inhibitors (ChEI), antioxidants (e.g., vitamin E), anti-inflammatory agents, estrogen, seligiline, vasoactive agents, and ginkgo biloba. Reviewing available data on these therapies and using models from medical illnesses such as cancer and hypertension, we highlight the urgent need for evaluating combination therapies in early AD.
Full Text
Duke Authors
Cited Authors
- Doraiswamy, PM; Steffens, DC
Published Date
- October 1998
Published In
Volume / Issue
- 46 / 10
Start / End Page
- 1322 - 1324
PubMed ID
- 9777922
Pubmed Central ID
- 9777922
Electronic International Standard Serial Number (EISSN)
- 1532-5415
International Standard Serial Number (ISSN)
- 0002-8614
Digital Object Identifier (DOI)
- 10.1111/j.1532-5415.1998.tb04556.x
Language
- eng